FluoroPharma Medical (FluoroPharma Medical) EV-to-Revenue : (As of Apr. 27, 2024)

FluoroPharma Medical EV-to-Revenue Chart

FluoroPharma Medical Annual Data
	Trend	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16
EV-to-Revenue		Get a 7-Day Free Trial					-	-	-	-	-

FluoroPharma Medical Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of FluoroPharma Medical's EV-to-Revenue

For the Biotechnology subindustry, FluoroPharma Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FluoroPharma Medical's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FluoroPharma Medical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where FluoroPharma Medical's EV-to-Revenue falls into.

FluoroPharma Medical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

FluoroPharma Medical's EV-to-Revenue for today is calculated as:

FluoroPharma Medical's current Enterprise Value is $0.00 Mil.
FluoroPharma Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FluoroPharma Medical  (OTCPK:FPMI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

FluoroPharma Medical's PS Ratiofor today is calculated as:

FluoroPharma Medical's share price for today is $0.0001.
FluoroPharma Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FluoroPharma Medical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of FluoroPharma Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

FluoroPharma Medical (FluoroPharma Medical) Business Description